ACS Applied Materials & Interfaces,
Год журнала:
2024,
Номер
17(1), С. 333 - 341
Опубликована: Дек. 17, 2024
Multidrug
resistance
of
tumor
cells
has
greatly
limited
the
chemotherapy
effect.
The
development
reliable
strategies
to
deal
with
multidrug
is
highly
desirable
for
therapy.
In
this
work,
a
near-infrared
II
(NIR
II)
luminogen
was
rationally
designed
and
prepared,
which
could
act
as
photothermal
reagent
reverse
drug
by
reducing
related
protein
expression,
achieving
high
inhibition
efficiency
synergistic
effect
chemotherapeutic
drugs.
By
selection
strong
electron-withdrawing
unit,
emission
peak
reach
973
nm.
Moreover,
shows
outstanding
conversion
ability
improved
thermal
stability
compared
ICG.
Notably,
after
treatment
drug-resistant
NIR
luminogen,
antitumor
drugs,
including
paclitaxel,
cis-platinum,
doxorubicin,
significantly
enhanced.
mechanism
exploration
revealed
that
resistance-related
proteins
were
remarkably
reduced,
making
more
sensitive
toward
Thus,
strategy
demonstrated
promising
approach
efficient
in
clinic.
Advanced Materials,
Год журнала:
2024,
Номер
36(27)
Опубликована: Март 29, 2024
Cancer
treatment
requires
precise
tumor-specific
targeting
at
specific
sites
that
allows
for
high-resolution
diagnostic
imaging
and
long-term
patient-tailorable
cancer
therapy;
while,
minimizing
side
effects
largely
arising
from
non-targetability.
This
can
be
realized
by
harnessing
exogenous
remote
stimuli,
such
as
tissue-penetrative
ultrasound,
magnetic
field,
light,
radiation,
enable
local
activation
therapy
in
deep
tumors.
A
myriad
of
nanomedicines
efficiently
activated
when
the
energy
stimuli
transformed
into
another
type
energy.
review
discusses
control
transformation
targetable,
efficient,
therapy.
Such
ultrasonic,
magnetic,
photonic,
radiative,
radioactive
mechanical,
thermal,
chemical,
radiative
to
a
variety
modalities.
The
current
article
describes
multimodal
where
serial
cascade
or
multiple
types
occur.
includes
not
only
hyperthermia,
radiation
but
also
emerging
thermoelectric,
pyroelectric,
piezoelectric
therapies
treatment.
It
illustrates
resonance,
fluorescence,
computed
tomography,
photoluminescence,
photoacoustic
imaging-guided
therapies.
highlights
afterglow
eliminate
autofluorescence
sustained
signal
emission
after
excitation.
Angewandte Chemie International Edition,
Год журнала:
2024,
Номер
63(44)
Опубликована: Июнь 28, 2024
Abstract
Given
that
type
I
photosensitizers
(PSs)
possess
a
good
hypoxic
tolerance,
developing
an
innovative
tactic
to
construct
PSs
is
crucially
important,
but
remains
challenge.
Herein,
we
present
smart
molecular
design
strategy
based
on
the
Förster
resonance
energy
transfer
(FRET)
mechanism
develop
photodynamic
therapy
(PDT)
agent
with
encouraging
amplification
effect
for
accurate
tumor
therapy.
Of
note,
benefiting
from
FRET
effect,
obtained
nanostructured
PDT
(NanoPcSZ)
boosted
light‐harvesting
ability
not
only
amplifies
superoxide
radical
(O
2
•‐
)
production
also
promotes
heat
generation
upon
near‐infrared
light
irradiation.
These
features
facilitate
NanoPcSZ
realize
excellent
phototherapeutic
response
under
both
normal
and
environments.
As
result,
in
vitro
vivo
experiments
achieved
remarkable
improvement
therapeutic
efficacy
via
combined
of
photothermal
action
photoreaction.
Notably,
can
be
eliminated
organs
(including
liver,
lung,
spleen,
kidney)
apart
site
excreted
through
urine
within
24
h
its
systemic
administration.
In
this
way,
potential
biotoxicity
drug
accumulation
avoided
biosafety
further
enhanced.
Near-infrared
(NIR)-triggered
type-I
photosensitizers
are
crucial
to
address
the
constraints
of
hypoxic
tumor
microenvironments
in
phototherapy;
however,
significant
challenges
remain.
By
selecting
an
electron-deficient
unit,
a
matched
energy
gap
upper-level
state
is
instrumental
boosting
efficiency
intersystem
crossing
for
electron
transfer
process.
2-Cyanothiazole,
acceptor,
covalently
linked
with
N,
N-diphenyl-4-(thiophen-2-yl)aniline
yield
multifunctional
photosensitizer
(TTNH)
that
exhibits
intrinsic
NIR
absorbance
and
compatible
T2
levels,
facilitating
both
radiative
nonradiative
transitions.
The
prepared
nanoparticles
(TTNH
NPs)
assembled
from
TTNH
activated
by
808
nm
laser
generated
O2•-
hypoxia-tolerant
photodynamic
therapy
under
normoxia
conditions.
NPs
emitted
NIR-II
fluorescence
impressive
quantum
2.08%.
With
high
photothermal
conversion
51.8%
stimulation,
exhibit
performance,
accompanied
enhanced
photoacoustic
imaging
capability
owing
their
strong
absorption.
These
characteristics
make
effective
NIR-wavelength-triggered
phototheranostic
agent
outperforms
fluorescence/photoacoustic
dual-model
imaging-guided
therapy/photothermal
against
tumors.
This
results
provide
valuable
insight
developing
high-performance
NIR-II-emissive
superoxide
radical
agents.
ABSTRACT
Prostate
cancer
is
an
epithelial
malignancy
with
a
high
incidence
among
elderly
men.
Photochemistry‐based
dye
photodrugs
(known
as
photosensitizers)
offer
promising
clinical
approach
for
treating
tumors.
These
agents
work
by
inducing
immunogenic
cell
death
(ICD),
which
activates
antitumor
immune
response.
This
favored
owing
to
its
minimal
invasiveness,
low
toxicity,
and
efficiency.
However,
the
immunosuppressive
microenvironment
of
characteristics
“cold”
tumors
significantly
restricts
efficacy
photodrugs.
Developing
advanced
nanocarrier
system
deliver
agonists
efficient
drug
delivery
tumor
lesion
sites
reshape
crucial
in
practice.
Therefore,
this
study,
we
designed
integrin‐targeted,
activatable
nano
photodrug
co‐assembly
agonist
(RPST@IMQ)
enhancing
photoimmunotherapy
prostate
via
reprogramming
tumor‐associated
macrophages.
The
active‐targeted
nanosystem
enhanced
dosage
at
site
through
systemic
administration.
High
doses
glutathione
cleaved
disulfide
bonds
RPST@IMQ,
releasing
imiquimod
(IMQ).
Under
photoirradiation,
generated
significant
singlet
oxygen
eliminate
cells,
thereby
ICD
activate
responses.
Simultaneously,
released
IMQ
reprograms
M2‐type
macrophages
(TAMs)
into
M1‐type
TAMs
tumor‐killing
capabilities,
converting
“hot”
conversion
enhances
therapeutic
against
primary
distant
vivo.
study
offers
new
insights
development
innovative,
smart,
enhance
anticancer
outcomes.
ABSTRACT
Imaging‐guided
phototherapy
holds
promise
for
precision
cancer
treatment.
However,
most
photosensitizers
have
only
a
singular
modality
of
photodynamic
therapy
(PDT)
or
photothermal
(PTT),
which
make
their
therapeutic
efficacy
severely
limited
by
the
hypoxic
and
complex
tumor
microenvironment
(TME).
In
this
article,
we
provide
smart
platform
design
(BOD‐D)
based
on
visualized
light‐triggered
phototherapeutic
switch
transforming
from
near‐infrared
(NIR)‐I
imaging‐guided
PDT
to
activatable
NIR‐II‐guided
PTT
while
releasing
nitric
oxide
(NO)
gas
(GT).
BOD‐D
releases
native
NIR
one‐region
fluorescence
signals
in
tumors,
is
used
direct
robust
killing.
As
administered,
decreasing
oxygen
content
TME
becomes
progressively
insufficient
maintain
its
excellent
cell‐killing
effect.
Subsequently,
light
triggers
dissociation
NO
BOD‐D,
activating
agent
BOD‐T
that
emits
NIR‐II
fluorescence,
subsequent
PTT.
Notably,
not
light‐mediated
mechanism
can
be
switched
NIR‐I‐guided
PTT,
but
also
released
during
process
will
GT
sensitize
above
Our
study
contributes
intelligent
cascade
photoablation.
Abstract
Photoswitchable
molecules
can
transit
between
two
distinct
isomers,
enabling
them
to
perform
highly
controllable
imaging
and
therapeutic
functions
under
certain
laser
irradiation.
Dithienylethenes
(DTEs),
a
class
of
photoswitchable
molecules,
exhibit
strong
thermal
stability
high
fluorescence
quantum
yield.
However,
the
short
excitation
wavelength
poses
significant
challenge
for
application
DTEs
in
photocontrolled
therapy.
Therefore,
development
DTE‐based
derivatives
or
hybrid
materials
with
near‐infrared
(NIR)
is
great
importance.
In
this
study,
novel
DTE
are
synthesized,
whose
closed‐ring
isomers
absorption
NIR
region.
Compared
derivative
previously
reported
commercially
available
ones,
these
show
higher
photoswitching
efficiency
extended
wavelength.
Notably,
supramolecular
assembly
albumin
confers
NIR‐activated
photothermal
switching
ability
on
aqueous
solution.
addition,
DTE‐albumin
nanoparticles
further
developed
enable
photoacoustic
(PAI)
therapy
(PTT)
vivo
antitumor
applications.
Finally,
by
integrating
thermo‐responsive
free
radical
initiator
into
nanoparticles,
PTT
chemodynamic
(CDT)
achieved,
effectively
inhibiting
tumor
growth
preventing
metastasis.
Advanced Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 26, 2025
Photo-immunotherapy
is
one
of
the
most
promising
cancer
treatment
strategies.
As
immunotherapeutic
agents,
immune
checkpoint
blockade
antibodies
against
programmed
cell
death
protein
1
(PD-1)
or
ligand
(PD-L1)
exhibit
substantial
potential,
but
have
to
face
non-specific
distribution
and
subsequent
immune-related
adverse
events.
Meanwhile,
high-performance
phototheranostic
agents
concurrently
possessing
multiple
modalities
high
light-harvesting
capacity
are
really
attractive
highly
desired
as
touching
modules.
Herein,
a
win-win
strategy
that
integrates
molecule
design
targeted
module
preparation
developed
construct
high-powered
photo-immunotherapy
systems.
Specifically,
agent
(AOTTIT)
displaying
typical
aggregation-induced
fluorescence
extending
second
near-infrared
II
window,
well
outstanding
reactive
oxygen
species
heat
production
first
obtained
via
ingenious
design.
Notably,
AOTTIT
exhibits
record
molar
extinction
coefficient
among
reported
organic
multimodal
molecules.
PD-1
genetically
engineered
membrane-derived
nanovesicles
(PD-1/CMNVs)
prepared
both
nanocarriers
camouflage
nanoparticles,
yielding
multifunctional
photo-immunotherapeutic
(CMNPs/PD-1)
with
tumor-specific
active
homologous
targeting
ability.
The
distinct
suppression
primary
metastatic
lung
tumors
after
only
once
tumor
substantiated
synergistically
strengthened
efficiency
this
strategy.
Advanced Functional Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 23, 2024
Abstract
Cancer
detection
and
inflammation
monitoring
during
photothermal
therapy
(PTT)
enable
timely
cancer
intervention
precise
control,
advancing
to
address
inflammation‐related
tumor
recurrence
metastasis
associated
with
PTT.
This
can
be
achieved
through
real‐time
biomarker
for
inflammation,
like
hypochlorous
acid
(HOCl),
a
highly
reactive
oxygen
species
(hROS)
in
body
elevated
levels
inflammation.
Here,
HOCl‐responsive
theranostic
nanoprobe
is
introduced,
AuNRs@SiO
2
‐CAA
ratiometric
photoacoustic
(PA)
emits
PA
signals
at
680
820
nm,
only
PA680
undergoing
changes
the
presence
of
HOCl,
enabling
HOCl
imaging
via
recording
(PA680/PA820).
exhibits
high
selectivity
sensitivity,
limit
0.34
µM
HOCl.
In
vivo,
it
effectively
detects
tumor,
drives
PTT,
monitors
PTT
by
sensing
The
successful
development
offers
novel
system
diagnosis,
poised
enhance
control.
Abstract
Microtubules
(MTs)
are
key
players
in
cell
division,
migration,
and
signaling,
they
regarded
as
important
targets
for
cancer
treatment.
In
this
work,
two
fullerene
(C
60
)‐functionalized
Ir(III)
complexes
(
Ir‐C
1
2
)
rationally
designed
dual
reactive
oxygen
species
(ROS)
regulators
MT‐targeted
Type
I/II
photosensitizers.
the
dark,
Ir
‐C
serve
ROS
scavengers
to
eliminate
O
•
−
•OH,
consequently
reducing
dark
cytotoxicity
reversing
dysfunctional
T
cells.
Due
efficiently
populated
C
‐localized
intraligand
triplet
state,
I
r
can
be
excited
by
green
light
(525
nm)
produce
•OONO
(Type
I)
II)
overcome
tumor
hypoxia.
Moreover,
is
also
able
photooxidize
tubulin,
interfering
with
cellular
cytoskeleton
structures,
inducing
immunogenic
death
inhibiting
proliferation
migration.
Finally,
exhibits
promising
photo‐immunotherapeutic
effects
both
vitro
vivo.
all,
we
report
here
first
MT
stabilizing
photosensitizer
performing
through
photodynamic
therapy
pathways,
which
provides
insights
into
rational
design
of
new
agents
targeting
specific
biomolecules.